Clinical Trial Update: Arimidex Bone Mass Index and Oral Bisphosphonates

View source ↗

Summary

A completed clinical trial evaluated the effects of anastrozole (Arimidex) on bone mass density in breast cancer patients when used with oral bisphosphonates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• ARIMIDEX (anastrozole)
• Ibandronate (ibandronate)
• alendronate (alendronate)
• risedronate (risedronate)

Snippet

Sponsor: Hellenic Breast Surgeons Society | Conditions: Breast Cancer, Bone Density | Status: COMPLETED